Navigation Links
NOVT Corporation Completes Reverse/Forward Stock Split
Date:7/22/2010

LOS GATOS, Calif., July 22, 2010 /PRNewswire-FirstCall/ -- NOVT Corporation (Pink Sheets: NVTPD) today announced that it has filed amendments to its Certificate of Incorporation effective as of July 9, 2010 that effected the previously announced 1-for-5,000 reverse stock split, pursuant to which shareholders owning fewer than 5,000 shares of NOVT's common stock have had their shares cancelled and converted into the right to receive $3.00 for each share of common stock held immediately prior to the reverse stock split. The amendments also effected a 50-for-1 forward stock split of the common stock immediately following the reverse stock split. As a result of the reverse stock split and forward stock split, there are currently 32,122 outstanding shares of common stock of NOVT. Finally, the amendments decreased the number of authorized shares of NOVT's common stock from 6,250,000 to 90,000 and decreased the number of authorized shares of NOVT's preferred stock from 1,250,000 to 10,000.

About NOVT Corporation

On March 9, 2006, NOVT completed the sale of substantially all the assets of its vascular brachytherapy business.  NOVT's strategic plan is to redeploy its existing resources to identify and acquire new business operations.  At this time, no candidates have been identified.  

NOVT's Certificate of Incorporation limits the ability of any person or group to acquire 4.75% or more of NOVT's common stock (subject to certain exceptions as provided in the Certificate of Incorporation) in order to protect NOVT's ability to utilize its net operating loss carryforwards and renders inapplicable to NOVT the limitations of Section 203 of the Delaware General Corporation Law.


'/>"/>
SOURCE NOVT Corporation
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Genaera Corporation Presents Interim Phase 1 Data for Obesity Compound Trodusquemine (MSI-1436) at IBC Conference
2. CEL-SCI Corporation Releases Letter to Shareholders
3. Alfacell Corporation to Present at UBS Global Life Sciences Conference
4. Baxa Corporation Extends Global Reach With New Distribution Agreements in Colombia and the Dominican Republic
5. Genaera Corporation Presents Preclinical Trodusquemine (MSI-1436) Data at the North American Association for the Study of Obesity Annual Meeting
6. Genaera Corporation Presents Phase 1 Data for Trodusquemine (MSI-1436) at the North American Association for the Study of Obesity Annual Meeting
7. The Quigley Corporation Reports Third Quarter Results, Increases Investment in Pharmaceutical R&D for Diabetic Neuropathy
8. Genaera Corporation Provides Highlights of Positive Phase 1 Trodusquemine (MSI-1436) Data from the North American Association for the Study of Obesity Annual Meeting
9. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on CEL-SCI Corporation
10. Immunosyn Corporation Releases SF-1019 Study Results
11. AmpliMed Corporation Announces Promising 1-year Survival Data from Phase I/II Study of Amplimexon(R) in Metastatic Malignant Melanoma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... 8, 2016  Haemonetics Corporation (NYSE: HAE ) ... System), an innovative software suite designed to help customers drive ... launch of NextGen DMS 4 improves core features and introduces ... per liter of plasma collected, enhancing quality and regulatory compliance ... ...
(Date:12/8/2016)... December 8, 2016 Stock-Callers.com revisits ... research, distribution, and marketing of pharmaceutical drug products. Companies ... protection and expiration. Additionally, these firms typically have dividend ... a whole. Up for review this morning are: Novo ... Inc. (NASDAQ: SGYP ), Pernix Therapeutics Holdings ...
(Date:12/8/2016)... Eli Lilly and Company (NYSE: ... abemaciclib, a cyclin-dependent kinase (CDK) 4 and CDK 6 ... Ki67, a biomarker of cell proliferation, after two weeks ... presented during the official press program at the 2016 ... alone or in combination with the non-steroidal aromatase-inhibitor anastrozole, ...
Breaking Medicine Technology:
(Date:12/7/2016)... PITTSBURGH, PA (PRWEB) , ... December 07, 2016 , ... ... and regular changing of the securement tape is painful for her. "This is why ... cannula’s to patients’ heads," she said. , They then created a prototype of the ...
(Date:12/7/2016)... ... 2016 , ... A. Kevin Spann Insurance, a New York-based firm offering insurance ... launching a charity drive to raise funds that will benefit the Marine Corps League. ... and Navy FMF Corpsmen. Working closely with the MCL, the A. Kevin Spann team ...
(Date:12/7/2016)... ... 07, 2016 , ... Sharon Kleyne, host of the nationally syndicated radio program, ... Voice of America, declared on her radio program in November 2016 the need to ... these bullies attack leaders in corporate America, they are trying to take advantage of ...
(Date:12/7/2016)... ... December 07, 2016 , ... Facial plastic surgeon, Dr. John D. Rachel ... a portion of proceeds to two local organizations: North Chicago Animal Control and Friends ... is a team of authorized and trained volunteers who support rescued animals held ...
(Date:12/7/2016)... Dallas, TX (PRWEB) , ... December 07, 2016 ... ... service based in Dallas, Texas, is condemning "scam operations" carried out by unethical ... to bring these scam operations to a halt. According to Texas Premier Locksmith, ...
Breaking Medicine News(10 mins):